Lin Ray, Tripuraneni Prabhakar
Department of Radiation Oncology, Scripps Clinic and Scripps Green Hospital, La Jolla, CA USA.
Indian J Surg Oncol. 2011 Jun;2(2):101-11. doi: 10.1007/s13193-011-0048-8. Epub 2011 May 6.
The treatment of breast cancer involves a multi-disciplinary approach with radiation therapy playing a key role. Breast-conserving surgery has been an option for women with early-stage breast cancer for over two decades now. Multiple randomized trials now have demonstrated the efficacy of breast-conserving surgery followed by radiation therapy. With the advancements in breast imaging and the successful campaign for early detection of breast cancer, more women today are found to have early-stage small breast cancers. Patient factors (breast size, tumor location, history of prior radiation therapy, preexisting conditions such as collagen vascular disease, age, having prosthetically augmented breasts), pathological factors (margin status, tumor size, presence of extensive intraductal component requiring multiple surgical excisions), as well as patient preference are all taken into consideration prior to surgical management of breast cancer. Whole-breast fractionated radiation therapy between 5 and 7 weeks is considered as the standard of care treatment following breast-conserving surgery. However, new radiation treatment strategies have been developed in recent years to provide alternatives to the conventional 5-7 week whole-breast radiation therapy for some patients. Accelerated partial breast radiation therapy (APBI) was introduced because the frequency of breast recurrences outside of the surgical cavity has been shown to be low. This technique allows treatments to be delivered quicker (usually 1 week, twice daily) to a limited volume. Often times, this treatment involves the use of a brachytherapy applicator to be placed into the surgical cavity following breast-conserving surgery. Accelerated hypofractionated whole-breast irradiation may be another faster way to deliver radiation therapy following breast-conserving surgery. This journal article reviews the role of radiation therapy in women with early-stage breast cancer addressing patient selection in breast-conserving therapy, a review of pertinent trials in breast-conserving therapy, as well as the different treatment techniques available to women following breast-conserving surgery.
乳腺癌的治疗采用多学科方法,放射治疗起着关键作用。二十多年来,保乳手术一直是早期乳腺癌女性的一种选择。多项随机试验现已证明保乳手术加放射治疗的疗效。随着乳腺成像技术的进步以及乳腺癌早期检测活动的成功开展,如今发现更多女性患有早期小乳腺癌。在对乳腺癌进行手术治疗之前,会综合考虑患者因素(乳房大小、肿瘤位置、既往放射治疗史、诸如胶原血管疾病等既往病症、年龄、乳房假体植入史)、病理因素(切缘状态、肿瘤大小、是否存在需要多次手术切除的广泛导管内成分)以及患者偏好。5至7周的全乳分割放射治疗被视为保乳手术后的标准治疗方案。然而,近年来已开发出新的放射治疗策略,为一些患者提供了传统5至7周全乳放射治疗的替代方案。加速部分乳腺放射治疗(APBI)被引入,因为已证明手术腔外乳腺复发的频率较低。这种技术可以更快地(通常为1周,每天两次)对有限体积进行治疗。通常,这种治疗涉及在保乳手术后将近距离放射治疗施源器放置到手术腔内。加速超分割全乳照射可能是保乳手术后进行放射治疗的另一种更快的方法。这篇期刊文章回顾了放射治疗在早期乳腺癌女性中的作用,涉及保乳治疗中的患者选择、保乳治疗相关试验的综述,以及保乳手术后女性可用的不同治疗技术。